At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
TMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Accelerated rTMS as a Treatment for Post-stroke Depression in the Subacute Phase: an Open Label Pilot Study
In Brief
A clinical study evaluating TMS for Post-stroke Depression. Completed, enrolled 6 participants across 1 site.
Detailed Summary
The purpose of this study is to find alternative treatments for patient's suffering from depression after having a stroke.This study aims to show that accelerated rTMS is a safe, effective,and convenient treatment for patient's suffering from post-stroke depression in the acute to subacute phase. This will be an open label trial and thus all participants will receive the active rTMS intervention.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-stroke Depression
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedSep 2019
Primary CompletionJun 2020
TodayJul 2026
First PostedSep 18, 2019
Enrollment StartOct 24, 2018
Primary CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.8 years ago
Interventions
TMSdevice
NeuroStar TMS Therapy